Hospital Pharmacy Leaders Call Staff Shortages, Vendor Management Their Biggest Operational Challenges

circular chart indicating percentage of hospital operated onsite pharmacies
Seventy-one percent of hospital pharmacy leaders surveyed said their facility offered at least one in-house outpatient and/or specialty pharmacy and over half of those lacking such a pharmacy said they planned to open one at some point.

Hospital outpatient pharmacy leaders cite staffing shortages, managing multiple vendors, and navigating insurer red tape—specialty drug referrals and prior authorization requirements, specifically—among top workplace challenges, a new survey finds. As 340B providers continue to grapple with pharmaceutical manufacturer contract pharmacy

Read More »

340B Report Publisher and CEO: What to Expect Following Midterm Elections

A roll of I Voted, Yo Vote stickers
Look for the GOP to try again to put more restrictions on the 340B program if the party takes over the U.S. House, 340B Report Publisher and CEO Ted Slafsky says.

Congress’ attitude toward the 340B program will likely change in 2023 and 2024 because of November’s midterm election results, 340B Report Publisher and CEO Ted Slafsky predicts in his latest column for Omnicell.

It is customary for the party that

Read More »
Industry Insights Logo

The Frustrating Realities of 340B ESP Data Submission

Kristin Fox-Smith
Kristin Fox-Smith, Visante, Inc.

SPONSORED CONTENT

For decades, the 340B drug pricing program has served an important purpose by helping hospitals and other covered entities receive discounted prices on drugs to offset care provided to vulnerable, underserved populations.

But over the past several years, drug companies have started pushing back on the 340B

Read More »

War Over Hearts and Minds in 340B Battle Heats Up as Hospitals Launch Their Own Campaign

example of a an ad advocating 340B program support of rural hospitals
Hospital groups are running ads aimed at getting HHS to" take all available enforcement actions" against drug companies that deny 340B pricing when providers use contract pharmacies.

It’s not just the drug industry stepping up its effort to influence the public and policymakers over the increasingly heated battle over the 340B program. 

Groups that represent 340B hospitals and hospital pharmacists have launched a digital advertising campaign “to

Read More »

U.S. Supreme Court Formally Notifies Lower Court and Parties About its Decision Striking Down Medicare Part B Drug Payment Cuts for 340B Hospitals

The Supreme Court of the United States building
Major hospital groups have asked the Supreme Court to review a case that challenges HHS' DSH payment formula.

The clerk of the U.S. Supreme Court on Monday formally notified the clerk of a federal appeals court in Washington, D.C., and lawyers for three hospital groups and three health systems of the high court’s June 15 judgement in the

Read More »
Industry Insights Logo

340B Advocacy – Preserving Underserved Health Care in America

SPONSORED CONTENT

In Democracy in America, French sociologist and political theorist Alexis de Tocqueville spoke of the importance of advocacy to American civil society: “In the United States, as soon as several inhabitants have taken an opinion or an idea they wish to promote in society, they seek

Read More »

340B DSH Hospitals Upped Services to the Poor During Pandemic’s Brutal First Year, 340B Health Says

Two bar charts comparing 340B DSH hospitals and Non-340B hospitals
Research commissioned by 340B Health found that 340B DSH hospitals spent more on uncompensated and unreimbursed care during COVID-19's first year than the year before despite worsening operating margins.

340B disproportionate share hospitals provided more uncompensated and unreimbursed care during 2020 despite a decline in operating margins associated with the COVID-19 pandemic, a new hospital-funded study shows.

The paper by Dobson DaVanzo for hospital group 340B Health compared 340B

Read More »

Senate Democrats Optimistic About Passing Drug Pricing Bill Before August Recess

Rachel Cohrs and Sen. Ron Wyden headshots
Senate Finance Chair Ron Wyden (right) said yesterday during a webinar moderated by STAT correspondent Rachel Cohrs (left) that Senate Democrats want to pass drug pricing legislation "right now, before everybody leaves for August."

U.S. Senate Democrats are hopeful that drug pricing legislation will be passed by early next month via a budget reconciliation process requiring just 50 Democratic votes, a Democratic source with knowledge of the process told 340B Report.

“Our expectation is, we’re

Read More »

As Part of New Ad Campaign, PhRMA Buys Full-Page Ad in Washington Post Blasting 340B Hospitals and Pharmacy Chains

PhRMA trade association ad about 340B
PhRMA ran a full-page ad in today's Washington Post saying 340B helps big hospitals and chain pharmacies, not patients.

Pharmaceutical Research and Manufacturers of America ran a full-page advertisement in the A section of The Washington Post this morning blasting 340B hospitals and drug store chains. According to a PhRMA spokesperson, it is part of a new ad campaign

Read More »

Hospital Groups Cheer, Private Cancer Docs Deplore CMS’s Decision to End Deep Cut in 340B Hospitals’ Drug Payments

Centers for Medicare & Medicaid Services wordmark
340B hospitals are happy that CMS has decided to end a deep cut in the hospitals' Medicare drug reimbursement. Private oncology practices call the decision "“an outrageous dereliction of duty."

Groups that represent 340B hospitals praised the Biden administration’s decision Friday to end a deep cut in the hospitals’ Medicare Part B drug reimbursement in place since 2018. They urged the government to swiftly make 340B hospitals whole for their

Read More »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×
×

*Sign up for news summaries and alerts from 340B Report

Site Footer Live